Biofine International Inc

Vancouver Biotech Limited (VBL), founded in 1988 by Dr. Gregory Lee, specializes in biotech research and development, particularly in the creation of proprietary monoclonal antibodies (MABs). With over 30 years of experience, VBL focuses on innovative solutions for immunodiagnostic products and medical devices aimed at treating human diseases, including cancer and fertility regulation. The company's notable projects include the development of MABs for applications in immunotherapy and cancer monitoring, as well as advancements in fertility regulation. VBL's work is grounded in a strong academic foundation, having previously collaborated with The University of British Columbia, where Dr. Lee served as a tenured professor for over three decades. Generated from the website

Artron BioResearch Inc., located in Burnaby, BC, specializes in the development and manufacture of various diagnostic tests including ELISA methods for hormonal and infectious agents. Their product line includes tested assays for HCG, LH, FSH, and TSH among others, steadying the forefront of medical diagnostics since 2016. The company has a commitment to quality and innovation, as evidenced by their various collaborations and product releases over the years. Artron continues to contribute to public health through reliable testing solutions, striving for excellence in the diagnostic industry. Generated from the website

Biolytical Laboratories Inc., located in Richmond, BC, is a leader in innovative point-of-care testing, focusing on rapid diagnostics for infectious diseases. Their flagship product, the INSTI HIV-1/2 Antibody Test, delivers trusted results in one minute with industry-leading accuracy, empowering patients and healthcare professionals alike. With a commitment to improving global health, Biolytical has products sold in 70 countries and has tested over 35 million individuals. The company harnesses proprietary flow-through technology to enhance patient care, aiming to shape a healthier future through biotech innovations. Generated from the website